Each week we highlight five things affecting the life sciences industry. Here's the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024--with early trials indicating improved patient outcomes and reduced disease ... READ MORE >
FDA
5 things to know in life sciences: Week of November 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the election might affect the life sciences industry Fierce Pharma provides some initial thoughts regarding the impact of Donald Trump’s election. Issues considered include changes to the Inflation ... READ MORE >
Medtech executives discuss regulatory collaboration, AI, strategic funding and more
What’s on the minds of the world’s top medtech executives? I recently attended AdvaMed’s medtech conference in Toronto to explore that question. The following includes some key takeaways from the event. Governmental agencies and medtech sector demonstrate a positive working relationship As someone who ... READ MORE >
5 things to know in life sciences: Week of October 14, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. German company announces positive results for a celiac disease trial Topas Therapeutics, a German biotech company, reported positive phase 2a results for its celiac disease candidate, showing a good safety ... READ MORE >
5 things to know in life sciences: Week of August 26, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA consolidates AI efforts The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research is merging its artificial intelligence activities under a single AI council to enhance safety and ... READ MORE >
5 things to know in life sciences: Week of July 8, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How will the FDA be affected by the Chevron ruling? The Supreme Court's decision to overturn the Chevron doctrine reduces judicial deference to federal agency interpretations of ambiguous statutes, ... READ MORE >
5 things to know in life sciences: Week of May 27, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA issues draft guidance on platform technology designation The Food and Drug Administration has released a draft guidance aimed at providing a framework for the designation of platform technologies, which ... READ MORE >
5 things to know in life sciences: Week of May 20, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New collaboration explores AI-based digital pathology Microsoft is collaborating with researchers from the University of Washington as well as Providence health network to develop a new artificial ... READ MORE >
5 things to know in life sciences: Week of May 13, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves new self-collection approach to cervical cancer screening According to the Washington Post, the Food and Drug Administration has approved a newly developed screening test for cervical cancer that ... READ MORE >
5 things to know in life sciences: Week of May 6, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma industry challenges Biosecure Act BioCentury reports that the biopharma industry is actively lobbying for changes to the Biosecure Act aiming to modify legislative measures that could impact U.S. ... READ MORE >